NCT04088461View on ClinicalTrials.gov

Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Prediabetic StateImpaired Glucose ToleranceInsulin Resistance
Interventions
DRUG

Linagliptin / Metformin Oral Tablet

Linagliptin 2.5 mg + Metformin 850 mg twice daily plus a lifestyle modifications program

DRUG

Metformin

Metformin 850 mg twice daily plus lifestyle modifications program

Trial Locations (1)

37670

Universidad de Guanajuato, León

All Listed Sponsors
collaborator

Hospital Regional de Alta Especialidad del Bajio

OTHER

lead

Universidad de Guanajuato

OTHER

NCT04088461 - Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine | Biotech Hunter | Biotech Hunter